815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Vertex said it has finished submitting its rolling Biologics License Application to the FDA for povetacicept, seeking accelerated approval for immunoglobulin A nephropathy in adults. Using a priority review voucher, the company expects the FDA review to take six months from the date the FDA accepts the application, rather than the typical ten months.
Rolling BLA for povetacicept in adults with IgAN submission completed
Company used a priority review voucher
Expected FDA review period: six months from acceptance, versus the typical ten months
DTE Electric, a DTE Energy subsidiary, entered into a Primary Supply Agreement and a Clean Capacity Accelerator Agreement with a Google LLC unit to serve a planned 1.0 gigawatt data center in southeast Michigan. The filing says the agreements include minimum monthly charges, possible termination fees, and a term through December 2047, and that Google's parent provides credit support. The filing does not give financial figures for the deal's revenue or earnings effect.
Primary Supply Agreement runs through December 2047 with extension options, covering a future 1.0 gigawatt data center in southeast Michigan
Clean Capacity Accelerator Agreement has DTE Electric deploy up to 480 megawatts of storage and 1,600 megawatts of renewable generation at Customer's cost, operated over a 20-year term
Customer provides about 300 megawatts of accredited capacity in MISO Zone 7 at no cost to DTE Electric; Board approved the agreements on March 16, 2026
Savara Inc. signed a lease on March 10, 2026 for about 10,795 square feet of office space in Yardley, Pennsylvania, where it plans to move its headquarters. The lease term starts July 1, 2026 and runs to December 1, 2031. The filing describes a routine facilities agreement with no financial results, guidance, or capital raise included.
Lease covers about 10,795 square feet at 19 W. College Avenue, Suite 200, Yardley, PA, with landlord ML7 Yardley Partners, LP
Term runs July 1, 2026 to December 1, 2031, with an option to extend five years
Monthly base rent of about $28,337 in year one, rising about 2% annually; aggregate base rent about $1.78 million after five months of abatement
Company has paid a security deposit equal to $28,337
Agape ATP Corporation, through subsidiary ATPC Green Energy Sdn. Bhd., entered a non-exclusive collaboration agreement dated March 6, 2026 with Citadel Investment LLC of Dubai to cooperate on sales and purchases of oil, gas, refinery and petrochemical products. The filing discloses no dollar value, revenue target or financial commitment, and the agreement may pay commissions or profit shares on transactions introduced under it.
Agreement dated March 6, 2026; press release issued the same day and furnished as Exhibit 99.1, with the form of agreement as Exhibit 99.2
Non-exclusive; cooperation covers oil and gas, refinery and petrochemical products, with commission or profit-sharing to be agreed per transaction
Initial term of 12 months, renewing automatically unless either party gives 30 days written notice; either party may terminate on 30 days written notice
Atlas Energy Solutions disclosed that its subsidiary ProjectCo entered a Global Framework Agreement with Caterpillar on March 4, 2026, reserving about 1.4 gigawatts of incremental power generation equipment. ProjectCo commits to an initial aggregate purchase obligation of approximately $840 million through December 31, 2030, which is a large long-term commitment for shareholders to weigh against future demand. The filing does not report revenue, earnings, or guidance effects from the agreement.
Agreement dated March 4, 2026 reserves about 1.4 GW of incremental power generation equipment with a term ending December 31, 2030.
Initial total aggregate purchase obligation of approximately $840 million, subject to annual escalations capped at 8% and tariff and shipping adjustments.
Annual capacity deposit of $5 million payable each June beginning in 2027, credited toward equipment purchase price.
If Caterpillar cannot reallocate unordered equipment, ProjectCo must purchase it; ProjectCo may be excused if a change in law makes performance illegal.
Amphastar's Chinese subsidiary ANP signed a five-year supply agreement with Nanjing Letop Biotechnology on March 3, 2026, for chemical intermediates, with no minimum purchase obligation. The company also amended a contract research agreement with Nanjing Hanxin, raising its total cost by about $0.6 million. Both counterparties are linked to the company's CEO and Chairman through family ownership, and the company states neither agreement is material to its financial condition or results of operations.
Supply Agreement with Letop signed March 3, 2026, for five years; ANP has no minimum purchase obligation
Contract Research Amendment with Hanxin raises total cost by about $0.6 million, shifting work from AMP-107 to AMP-105
Letop and Hanxin are related parties; Audit Committee evaluated and approved both deals
Company states neither agreement is material to its financial condition or results of operations
On February 26, 2026, subsidiary Hainan Helpson Medical & Biotechnology agreed to acquire the ownership of an invention patent for Prinsepia Utilis Esterol Sublingual Tablets from Xiaoyan Zhang. The $6.93 million transfer price will be paid in company common stock at $0.55 per share, meaning the company is to issue 12,600,000 restricted shares that are not registered under the Securities Act.
Agreement dated February 26, 2026, between subsidiary Helpson and Xiaoyan Zhang, a technology transfer covering an invention patent for sublingual tablets
Transfer price of $6.93 million, paid in common stock at $0.55 per share
Company to issue an aggregate of 12,600,000 restricted shares, offered under the Regulation S exemption to a non-U.S. person in an offshore transaction
Transferor or a designated third party will provide technical services, including product research and development and registration support
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.